{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:13:21Z","timestamp":1791357201859,"version":"4.3.1"},"reference-count":13,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2005,8,2]],"date-time":"2005-08-02T00:00:00Z","timestamp":1122940800000},"content-version":"vor","delay-in-days":1858,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2000,7]]},"abstract":"<jats:p><jats:bold>Summary: <\/jats:bold>  <jats:italic>Purpose<\/jats:italic>: To examine a patient with valproic acid (VPA)\u2010induced hyperammonemic encephalopathy accompanied by triphasic waves.<\/jats:p><jats:p> <jats:italic>Methods<\/jats:italic>: A 61\u2010year\u2010old male patient with epilepsy experienced disturbance of consciousness after VPA dose was increased because of poor seizure control. The electroencephalogram (EEG) taken on admission revealed triphasic waves and high\u2010amplitude \u03b4\u2010activity with frontal predominance. Although serum hepatic enzymes, such as AST and ALT, were normal, serum ammonium level was high at 96 \u03bcg\/dl (normal range, 3\u201347 \u03bcg\/dl). Serum amino acid analysis showed multiple minor abnormalities. Administration of VPA was discontinued immediately after admission, while other anticonvulsants were continued.<\/jats:p><jats:p> <jats:italic>Results<\/jats:italic>: The patient's condition was improved on the fourth day of admission. An EEG, serum ammonium level, and amino acid profile were normal on the eighth day. Based on VPA administration, serum ammonium levels, and results of amino acid analysis, this patient had VPA\u2010induced hyperammonemic encephalopathy.<\/jats:p><jats:p> <jats:italic>Conclusions<\/jats:italic>: Our case indicates that caution is required if triphasic waves appear in VPA\u2010induced hyperammonemic encephalopathy.<\/jats:p>","DOI":"10.1111\/j.1528-1157.2000.tb00263.x","type":"journal-article","created":{"date-parts":[[2005,8,3]],"date-time":"2005-08-03T06:35:48Z","timestamp":1123050948000},"page":"909-912","source":"Crossref","is-referenced-by-count":48,"title":["Valproic Acid\u2010Induced Hyperammonemic Encephalopathy with Triphasic Waves"],"prefix":"10.1111","volume":"41","author":[{"given":"Akira","family":"Kifune","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyoshi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takushirou","family":"Akata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senichirou","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,8,2]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1979.tb04853.x"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(81)80489-1"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410110315"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.32.2.206"},{"key":"e_1_2_1_6_2","first-page":"313","article-title":"Nondosage\u2010dependent valproic acid\u2010induced hyperammonemia and coma","volume":"3","author":"Gaskins JD","year":"1984","journal-title":"Clin Pharmacy"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000115687"},{"key":"e_1_2_1_8_2","first-page":"1247","article-title":"A case of valproate\u2010induced hyperammonemic encephalopathy","volume":"14","author":"Uchida S","year":"1985","journal-title":"Jpn J Clin Psychiat"},{"key":"e_1_2_1_9_2","first-page":"1067","article-title":"A case of epilepsy accompanied by hyperammonemia and coma during antiepileptic therapy","volume":"28","author":"Sueyoshi T","year":"1986","journal-title":"Clin Psychiat"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.292.6512.23"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.64.5.680"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-198106000-00020"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)91481-3"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0013-4694(88)90188-5"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1528-1157.2000.tb00263.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1528-1157.2000.tb00263.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T08:52:33Z","timestamp":1698569553000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1528-1157.2000.tb00263.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["10.1111\/j.1528-1157.2000.tb00263.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1528-1157.2000.tb00263.x","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}